Mystbio

Mystbio is a molecular diagnostics reagent developer that focuses on the emerging disease spectrum in cancer treatment and specializes in developing molecular diagnostic reagents and intelligent diagnostic technologies. It builds a medical data platform and chronic disease management system, using side effects of cancer treatment as an entry point to integrate fragmented health data, aiming to establish a closed-loop from "new target discovery to intelligent product implementation," promoting the digitalization and intelligent development of integrated cancer diagnosis and treatment.